Related Subjects: Thrombophilia testing
|Antiphospholipid syndrome
|Protein C Deficiency
|Protein S Deficiency
|Prothrombin 20210A mutation
|Factor V Leiden Deficiency
|Antithrombin III deficiency (AT3)
|Cerebral Venous Sinus thrombosis
|Budd-Chiari syndrome
๐งฌ Protein S Deficiency: Thrombophilia & Clinical Significance
๐ง Introduction
Protein S deficiency is a rare inherited or acquired thrombophilia.
Protein S is a vitamin Kโdependent glycoprotein that serves as a cofactor for activated protein C (APC), helping to inactivate factors Va and VIIIa.
Deficiency โ uncontrolled thrombin generation โ venous thromboembolism (VTE) such as DVT, PE, and cerebral venous sinus thrombosis (CVST).
๐ Epidemiology
- Prevalence: 0.03โ0.13% in the general population; 1โ7% in patients with VTE.
- Inheritance: Autosomal dominant, variable penetrance.
- Affects all ethnic groups equally.
๐งฌ Genetics & Pathophysiology
Mutations in the PROS1 gene (chromosome 3q11.2). Protein S circulates in two forms:
- ๐ข Free Protein S: active form (cofactor for APC).
- โช Bound Protein S: inactive, attached to C4b-binding protein.
Types of deficiency:
- Type I: โ total + free antigen + โ activity.
- Type II: normal antigen, โ activity (dysfunctional protein).
- Type III: normal total antigen, โ free antigen + โ activity.
๐ฉบ Clinical Features
- ๐ก๏ธ Venous Thromboembolism (VTE): Early-onset (<50), recurrent DVT/PE, provoked or spontaneous.
- ๐ง Cerebral Venous Sinus Thrombosis (CVST): Headache, papilloedema, seizures, focal deficits.
- โค๏ธ Arterial Thrombosis: Less common; stroke/MI in high-risk settings.
- ๐คฐ Pregnancy: Miscarriage, IUGR, pre-eclampsia, placental abruption, โ VTE risk.
- โ ๏ธ Warfarin-Induced Skin Necrosis: Rare complication when warfarin started without heparin bridging.
โ ๏ธ Risk Factors & Triggers
- Hormones (OCPs, HRT).
- Pregnancy / postpartum.
- Surgery, trauma, immobilisation.
- Obesity, smoking, malignancy.
- Other thrombophilias (FVL, prothrombin G20210A).
- Antiphospholipid antibody syndrome.
๐งช Diagnosis
- Clinical history: VTE at young age, family history.
- Laboratory tests:
- Total protein S antigen.
- Free protein S antigen (active form).
- Protein S activity assay (functional).
- Other coagulation work-up: Protein C, antithrombin III, Factor V Leiden, prothrombin mutation, APC resistance.
- Imaging: Doppler US (DVT), CTPA (PE), MRV (CVST).
โ ๏ธ Levels fall in acute thrombosis, pregnancy, OCP use, warfarin, liver disease โ test in steady state and off anticoagulation.
๐ Differentials
- Protein C deficiency
- Antithrombin deficiency
- Factor V Leiden
- Prothrombin G20210A mutation
- Antiphospholipid syndrome
- DIC
- Lupus anticoagulant
- HIT
๐ก๏ธ Management
Preventive Measures
- Lifestyle: weight control, exercise, stop smoking, avoid immobility.
- Avoid oestrogen-containing OCP/HRT where possible.
- Pregnancy: consider LMWH prophylaxis in high-risk women; close obstetric monitoring.
Treatment of Acute Thrombosis
- ๐ LMWH or unfractionated heparin โ transition to warfarin or DOACs (rivaroxaban, apixaban) โ specialist input recommended.
- โ ๏ธ Warfarin-induced skin necrosis: stop warfarin, give vitamin K, restart heparin, consider protein C concentrate.
- Duration: 3โ6 months (provoked first VTE), longer if recurrent/unprovoked or high risk.
๐
Long-Term Anticoagulation
- Individualised: balance recurrence vs bleeding risk.
- Indefinite anticoagulation often needed in recurrent cases.
- Regular follow-up essential.
๐จโ๐ฉโ๐ง Genetic Counselling
- Offer to affected families with strong thrombotic history.
- Educate on warning signs of VTE (leg swelling, chest pain, dyspnoea).
- Discuss risk during pregnancy and surgery.
๐ Prognosis
- Many live normal lives with risk-modifying measures.
- Recurrent VTE risk persists โ vigilance needed.
- Pregnancy can be safe with prophylaxis and monitoring.
๐ References
- Dahlbรคck B. Discovery of protein S function. ATVB. 2007.
- Patel JP et al. Protein S deficiency and pregnancy. Thromb Haemost. 2015.
- Miles JS et al. Importance of free protein S measurement. Br J Haematol. 1996.
- NICE Guideline NG158: VTE disease, 2020.
- James AH. Thrombophilia in pregnancy. Obstet Gynecol Surv. 2001.